
The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

Older age and higher educational level were associated with only the conditional probability of an individual treatment professional being perceived as helpful.

Investigators estimate 40-50% of proton pump inhibitor users are using inappropriately.

Investigators find a greater increase in positive symptoms after a ketamine infusion when compared to placebo.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

Understanding and addressing clinician burnout need to be prioritized at a system and local level.

Maternal antenatal depressive symptoms also linked to offspring depression at age 18.

The virtual version of cognitive behavioral therapy could yield significant healthcare cost savings.

New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.

Despite patients being off treatment for an average of 23 months, patients treated with Eisai’s BAN2401 remained amyloid PET negative in an open-label extension preliminary analysis.

Social distancing measures could increase the risk of psychotic symptoms.

Because symptoms can manifest differently in each patient, some individuals with schizophrenia have handled social isolation better than others.

The findings highlight the importance of improving emergency department preparedness.

A combination of medications and therapy is viewed as the most effective method of treating schizophrenia.

A physician's assistant for Oasis Lifecare discusses some of the new and promissing treatments for schizophrenia.

Flortaucipir PET tracer’s can identify high levels of neuropathologic changes and neurofibrillary tangles.

A new study finds a multitude of factors involving organizational, interpersonal, and intrapersonal influences lead to trauma in frontline caregivers.

An assessment of survey data show patients with severe depressive or psychological symptoms are more likely to be dissatisfied with their dermatologist.

Disruption at home linked to an increase in the risk of developing major depression.

Older patients with worse sleep patterns who are treated for depression need further clinical attention.

Telemedicine could eliminate some of the distance barriers in rural areas.